What are the diagnostic approaches for perimenopausal bleeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diagnosing perimenopausal bleeding requires a comprehensive approach including medical history, physical examination, and appropriate testing, with a focus on ruling out structural and nonstructural causes of abnormal uterine bleeding, as outlined in the PALM-COEIN classification system 1. To diagnose perimenopausal bleeding, the following steps should be taken:

  • Obtain a detailed menstrual history, noting changes in frequency, duration, and heaviness of bleeding, as well as associated symptoms like hot flashes, mood changes, and sleep disturbances.
  • Perform a complete physical examination, including a pelvic examination, to check for anatomical causes.
  • Laboratory tests should include a complete blood count to assess for anemia, thyroid function tests, and hormone levels including FSH, estradiol, and progesterone.
  • Transvaginal ultrasound is essential to evaluate endometrial thickness and identify structural abnormalities like fibroids or polyps, as recommended by the American College of Radiology 1.
  • If the endometrial thickness exceeds 4-5mm or bleeding is persistent, an endometrial biopsy should be performed to rule out hyperplasia or malignancy.
  • Saline infusion sonography or hysteroscopy may be needed for further evaluation of intracavitary lesions. The goal of these diagnostic steps is to distinguish between normal perimenopausal changes and concerning pathology that requires intervention, and to identify the underlying cause of the bleeding, whether it be structural, such as polyps or fibroids, or nonstructural, such as ovulatory dysfunction or coagulopathy 1. The most recent and highest quality study, published in 2020, recommends a thorough history, physical examination, and appropriate laboratory tests, as well as imaging to assess for structural abnormalities, as the initial steps in the diagnosis of perimenopausal bleeding 1.

From the Research

Diagnostic Approach

To diagnose perimenopausal bleed, the following steps can be taken:

  • A thorough medical history and physical examination should be conducted to identify any underlying causes of abnormal uterine bleeding 2, 3
  • A speculum examination should be performed to exclude cervical and vaginal causes of abnormal uterine bleeding 2
  • Laboratory tests such as measurement of haemoglobin and iron levels, human chorion gonadotropin, and thyroid hormones may be relevant in selected cases 2, 4
  • Transvaginal ultrasound is an ideal first step for the evaluation of perimenopausal abnormal uterine bleeding, and saline or gel contrast sonohysterography can improve diagnostic accuracy 2, 3

Exclusion of Other Causes

The following causes should be excluded:

  • Sexually transmitted diseases or pregnancy should be ruled out 2
  • Thyroid disease, which can be challenging to diagnose in perimenopausal women, should be considered 4
  • Bleeding disorders, such as von Willebrand's disease, should be investigated if suspected 5

Further Evaluation

Based on the initial evaluation, further testing may be necessary:

  • Endometrial biopsy or hysteroscopy may be planned if premalignant or malignant causes are suspected 2, 6
  • Endometrial tissue sampling may be necessary in women at high risk for endometrial cancer or in those who do not respond to medical treatment 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Abnormal uterine bleeding in perimenopause.

Climacteric : the journal of the International Menopause Society, 2017

Research

Thyroid disease in the perimenopause and postmenopause period.

Climacteric : the journal of the International Menopause Society, 2018

Research

Bleeding and bruising: a diagnostic work-up.

American family physician, 2008

Research

Management of pre-, peri-, and post-menopausal abnormal uterine bleeding: When to perform endometrial sampling?

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2022

Related Questions

What is the workup for a perimenopausal patient with mittelschmerz (ovulation pain), abnormal uterine bleeding (AUB), and a history of ovarian cysts with rupture?
What is the recommended management for a 48-year-old female with normal hormone levels and an endometrial thickness of 1.40cm presenting with abnormal uterine bleeding?
What is the next step in managing a perimenopausal woman with irregular bleeding and menopausal range serum FSH (Follicle-Stimulating Hormone) levels?
What is the cause of abnormal bleeding with a normal prothrombin time (PT)?
What further testing is indicated for a 29-year-old female with easy bruising and normal coagulation studies, including normal Partial Thromboplastin Time (PTT), Complete Blood Count (CBC), and International Normalized Ratio (INR)?
What is the recommended frequency and interval for investigations to monitor mild-to-moderate aortic regurgitation (AR) with normal left ventricular ejection fraction (LVEF) and minimal symptoms in a 65-year-old patient, and does aortic regurgitation (AR) always progress in severity?
Is a combination of background Right Bundle Branch Block (RBBB) with First-Degree Atrioventricular Block (FD-AVB) and alternating Left Anterior Hemiblock (LAHB) and Left Posterior Hemiblock (LPHB) concerning for potential Complete Heart Block (CHB)?
What are the next steps for an 18-year-old patient experiencing persistent anxiety while taking fluoxetine (Prozac) 10mg, aripiprazole 2mg, and hydroxyzine 25mg?
What is the recommended pediatric dosing for Rupall (Rupatadine)?
When to discontinue high-dose Lorazepam (benzodiazepine) in a male patient with resolved catatonia, now presenting with delirium and elevated C-reactive protein (CRP), and fluctuating levels of sedation?
When to discontinue high-dose Lorazepam (benzodiazepine) in a male patient with resolved catatonia, now presenting with delirium and elevated C-reactive protein (CRP), and fluctuating levels of sedation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.